Venture Certified
| 기술평가보증기업(기금) | 2018-04-05 ~ 2020-04-04 | 20180103768 | 2018-04-05 |
| 연구개발유형 | 2022-06-08 ~ 2025-06-07 | 20220608020024 | 2018-04-05 |
| 연구개발유형 | 2025-06-08 ~ 2028-06-07 | 20250702020001 | 2018-04-05 |
Revenue CAGR +70.1%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 31.9B | 33.8B | 11.0B |
| Operating Profit | -3.2B | 0.5B | 1.4B |
| Net Profit | -3.4B | 0.6B | 2.6B |
| Total Assets | 48.4B | 39.1B | 35.4B |
| Total Liabilities | 24.7B | 12.1B | 9.0B |
| Total Equity | 23.7B | 27.1B | 26.4B |
Operating Loss: Op. profit -3B
Debt Ratio Surge (+60pp YoY)
▲ 42.2%
▼ 438.4%
▼ 241.9%
▲ 165.5%
▼ 337.8%
| Name | Position | Role |
|---|---|---|
| 신남철 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울 구로구",
"ceo_name": "신남철",
"certificate": [
{
"cert_number": "20180103768",
"changes": "",
"disclosure_date": "2018-04-05",
"first_cert_date": "2018-04-05",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-04-05 ~ 2020-04-04"
},
{
"cert_number": "20220608020024",
"changes": "",
"disclosure_date": "2022-06-08",
"first_cert_date": "2018-04-05",
"no": "2",
"type": "연구개발유형",
"valid_period": "2022-06-08 ~ 2025-06-07"
},
{
"cert_number": "20250702020001",
"changes": "",
"disclosure_date": "2025-07-02",
"first_cert_date": "2018-04-05",
"no": "3",
"type": "연구개발유형",
"valid_period": "2025-06-08 ~ 2028-06-07"
}
],
"company_name": "(주)움트",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 336500000,
"cost_of_sales": 19908000,
"current_assets": 1871813000,
"current_liabilities": 896837000,
"gross_profit": 1082303000,
"net_income": 258051000,
"net_income_bs": 258051000,
"non_current_assets": 1665673000,
"non_current_liabilities": 0,
"non_operating_expenses": 60445000,
"non_operating_income": 180276000,
"operating_profit": 138220000,
"revenue": 1102211000,
"sga_expenses": 944083000,
"total_assets": 3537486000,
"total_equity": 2640649000,
"total_liabilities": 896837000
},
"2023": {
"capital_stock": 338350000,
"cost_of_sales": 0,
"current_assets": 1956293000,
"current_liabilities": 988099000,
"gross_profit": 3382358000,
"net_income": 59574000,
"net_income_bs": 59359000,
"non_current_assets": 1953785000,
"non_current_liabilities": 216937000,
"non_operating_expenses": 38694000,
"non_operating_income": 49594000,
"operating_profit": 48674000,
"revenue": 3382358000,
"sga_expenses": 3333684000,
"total_assets": 3910078000,
"total_equity": 2705042000,
"total_liabilities": 1205036000
},
"2024": {
"capital_stock": 338350000,
"cost_of_sales": 4438000,
"current_assets": 3097603000,
"current_liabilities": 2341296000,
"gross_profit": 3183402000,
"net_income": -337178000,
"net_income_bs": -337178000,
"non_current_assets": 1738244000,
"non_current_liabilities": 126687000,
"non_operating_expenses": 76511000,
"non_operating_income": 55518000,
"operating_profit": -316185000,
"revenue": 3187840000,
"sga_expenses": 3499587000,
"total_assets": 4835847000,
"total_equity": 2367864000,
"total_liabilities": 2467983000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "의약품의료기기 연구개발",
"phone": "070-4818-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |